Virax Biolabs Group Limited Annual and transition report of foreign private issuers pursuant to Section 13 or 15(d)

Annual and transition report of foreign private issuers pursuant to Section 13 or 15(d)

Inventories (Tables)

Inventories (Tables)

12 Months Ended

Mar. 31, 2023

Classes of current inventories [abstract]

Summary of Inventories


		As of March 31,
		2023				2022
Finished goods			20,951				30,951
Inventory write down			(20,951	)			(10,000	)
Inventory, net			—				20,951